Metabolomics and integrated network pharmacology analysis reveal SNKAF decoction suppresses cell proliferation and induced cell apoptisis in hepatocellular carcinoma via PI3K/Akt/P53/FoxO signaling axis

Abstract

Background There is no comprehensive treatment method for hepatocellular carcinoma (HCC); hence, research and development are still focused on systemic therapies, including drugs. Sinikangai fang (SNKAF) decoction, a classic Chinese herbal prescription, has been widely used to treat liver cancer. However, there is no research on its core active component and target. Methods Mouse models were established to measure the anticancer effect of SNKAF decoction on HCC. Further, we investigated the effect of SNKAF decoction on inhibition of hepatoma cells proliferation using cell viability, cloning and invasion assays in vitro. The components of SNKAF were collected from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and TCM@Taiwan database. Metabolomic analysis was used to identify the potential genes and pathways in HCC treated with SNKAF decoction. Then, the expression of phosphoinositide 3-kinase (PI3K), Akt, P53, FoxO proteins of the potential signal pathways were detected using Western blot. Results The animal experiments showed that SNKAF decoction inhibited tumor growth (P < 0.05) and induced no weight loss in the mice. In vitro data showed that HCCLM3 and MHCC97H cell proliferation was inhibited by SNKAF serum in a time- and concentration dependent manner. Further combined analysis network pharmacology with metabonomics showed that 217 target genes overlapped. The core target genes included BCL2, MCL1, Myc, PTEN, gsk3b, CASP9, CREB1, MDM2, pt53 and CCND1. Cancer-associated pathways were largely involved in SNKAF mechanisms, including P53, FoxO, and PI3K/Akt signaling pathways, which are closely related to induced-tumor cell apoptosis. In addition, Western bolt verified that 10% SNKAF serum significantly affected the main proteins of PI3K/Akt/P53/FoxO signaling pathway in both cell lines. Conclusion SNKAF decoction-containing serum inhibited HCCLM3 and MHCC97H cell proliferation, migration, invasion, and induced-tumor cell apoptosis in-vivo. We confirmed that SNKAF decoction is a promising alternative treatments for HCC patients.

Exosomes Derived from Hypoxic Glioma Cells Reduce the Sensitivity of Glioma Cells to Temozolomide Through Carrying miR-106a-5p

“…PTEN was known to be an inhibitor of cell growth, which could suppress tumor progression. 36 , 37 In addition, PTEN was confirmed to inhibit the cell growth via inactivation of Akt signaling. 38 , 39 Consistently, this research found exosomes derived from hypoxic glioma cells could reduce the expression of PTEN and upregulate the level of p-Akt in TMZ-treated glioma cells.…”

Celestial Insights: Unraveling the Role of miR-3682-3p in Hepatocellular Carcinoma

“… FoxO signaling pathway: FoxO proteins participate in regulating the cell cycle, apoptosis, and antioxidant responses ( 40 , 41 ). In liver cancer, the FoxO pathway may play a role in regulating tumor cell survival, proliferation, and metabolism ( 42 ). Arachidonic acid metabolism: The arachidonic acid metabolism pathway is related to inflammation, tumor growth, and invasion ( 43 ).…”

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma

“…To further explore the cell deaths modalities in HCC, we performed GSEA and GSVA and finally identified that apoptosis was significantly suppressed in HCC. Since cell cycle and cell death exert significant effects on tumor growth, they serve as tumor therapeutic targets 38 . By bioinformatics analysis, we identified CD69, CDC25B, MGMT, TOP2A, and TXNIP as candidate genes.…”